Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Isracann Biosciences
Isracann Biosciences
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Isracann Biosciences
Stock Price
$0
2024-10-29
Market Capitalization
$2 M
2024-10-29
Isracann Biosciences Summary
Company Summary
Overview
Isracann Biosciences is a pharmaceutical company. It offers medical research and cannabis cultivation, distribution, manufacturing, and branding solutions.
Type
Public
Status
Active
Founded
2018
HQ
Vancouver, CA
|
view all locations
Website
https://isracann.com
Cybersecurity rating
Sectors
Healthcare
distribution
drug development
pharma
Homepage
Linkedin
instagram
facebook
youtube
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Vancouver, BC
HQ
Canada
1600-595 Burrard Street
Isracann Biosciences Financials
Summary Financials
Net income (Q1, 2023)
($C316.0K)
Cash (Q1, 2023)
$C198.0K
EBIT (Q1, 2023)
($C86.0K)
Enterprise value
$1.8M
Competitors and Similar Companies
Quantum Pharmaceutical
Healthcare - Subsidiary
AOP Orphan Pharmaceuticals
Healthcare - Private
Grupo Menarini
Healthcare - Private
Zydus Lifesciences
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top